附属北京佑安医院-粟斌导师介绍
粟斌
教授
硕，博士生导师
男
附属北京佑安医院
内科学（传染病）
,内科学
HIV感染与免疫应答、艾滋病“功能性治愈”及新发突发传染病
binsu@ccmu.edu.cn
粟斌，留法病毒学博士，首都医科大学附属北京佑安医院研究员、首都医科大学教授、博士生导师。担任科技部中法艾滋病研究联合实验室主任、北京佑安医院中心实验室主任、艾滋病实验室主任、科技成果转化中心副主任、以及首都医科大学艾滋病临床诊疗与研究中心（佑安）执行副主任。曾兼任国家自然科学基金委员会医学科学部医学科学六处感染科学/检验医学流动编制项目主任。入选科技部首批中法杰出青年科研人员、国家疾控局公共卫生人才（病原学鉴定方向）、北京市第十二批海外高层次人才（北京市特聘专家）、北京市“高创计划·登峰”人才（临床研究型）、北京市高层次公共卫生技术人才-学科带头人（病原鉴定、诊断和检测专业方向），以及全球前2%顶尖科学家（临床医学-病毒学领域）。荣获北京市科学技术进步奖二等奖两次，以及江苏省科学技术奖二等奖。担任中华医学会医学病毒学分会常务委员、中国免疫学会感染免疫分会常务委员、北京医学会医学病毒学分会常务委员兼秘书、北京防痨协会结核病基础专业分会常务委员、北京海外高层次人才协会理事，以及国家卫生健康委员会全球卫生人才后备库成员等社会职务，高级技术经理人。
粟斌2010年博士毕业于法国巴黎第七大学，2011-2015年在法国斯特拉斯堡大学和法国国家健康与医学研究院（INSERM）从事HIV感染发病机制及艾滋病疫苗的研发工作。2015年底归国后从事HIV感染与免疫应答、艾滋病功能性治愈、新发突发传染病、以及生物医药技术转移转化的工作，主持国家重点研发计划（项目和课题负责人）、“十三五”传染病重大专项（子任务负责人）、国家自然科学基金重点国合1项/面上项目3项/原创探索计划项目1项，以及北京市自然科学基金重点项目等10余项国家级和省部级项目。截至2025年底，已在Cell、NEJM等国际学术专业期刊上发表SCI论文170余篇（其中第一或通讯作者发表SCI论文100篇），中文核心63篇，被邀请作为The Lancet HIV、Chinese Medical Journal、中国艾滋病性病 等30余个中外期刊的副主编、编委和审稿人。人民卫生出版社《艾滋病学》副主编。
展开更多
科研项目
1. 国际上首次合作在人体内探索了基于CRISPR/Cas9技术的成体造血干细胞基因编辑技术，证实了其在患有艾滋病合并白血病患者中移植的可行性和安全性（NEJM 2019），为艾滋病的临床治愈带来了跨越性进展；
2. 阐明了HIV 感染的免疫发病机制，代谢、转录后调控等与HIV 感染者免疫重建不良的发生机制及其影响因素，填补了相关领域空白（Infection 2024, Chin Med J 2024, 2023&2022, J Med Virol 2023&2022, JAMA Netw Open 2022, Front Immunol 2025, 2022&2021, Lancet Glob Health 2021, J Leukoc Biol 2020, Blood 2012）；
3. 围绕国家重大战略需求，以临床问题为导向，开展多项全国多中心艾滋病药物III期临床试验，促进我国原研抗艾新药迈出国门，让患者有了更多的用药选择（Chin Med J 2024, Lancet Reg Health West Pac 2023, J Infect 2022, Chin Med J 2020, Front Pharmacol 2019）；
4. 通过高通量单细胞测序快速筛选出强效的抗病毒全人源单克隆中和抗体，并联合参与组建“新冠肺炎单细胞研究中国联盟”，揭示了新冠病毒感染发病机制和免疫学特征等（Cell 2021&2020, Chin Med J 2022, Front Immunol 2021, Sci China Life Sci 2021, Cell Mol Immunol 2020）。
展开更多
研究成果
1. Xiao J, Wang F, Zhu L, Liu Y, Su B*, Lu X*, Zhang T*. Residual Exhaustion of Stem Cell-Like Memory T Cells (TSCM) in HIV Infected Patients With Viral Suppression. JOURNAL OF MEDICAL VIROLOGY, 2025 Dec;97(12):e70761.
2. Jia J#, Zheng HY#, Zhao Y#, Gao KC, Kong D, Lu D, Yang JQ, Mao JH, Wang X, Wang KH, Su B*, Wang JH*, Zheng YT*, Kuang YQ*. A decreased proportion of naïve MAIT cells is associated with the incomplete immune reconstitution in antiretroviral therapy-treated HIV-1 patients. VIROLOGICA SINICA, 2025 Dec 4:S1995-820X(25)00170-1.
3. Jin J#, Xu Q#, Zhang X#, Zhu A, Xia W, Moog C*, Chan ASW*, Zhang T*, Su B*. HIV infection and immunosenescence: challenges and intervention strategies. BMC MEDICINE, 2025 Dec 2. doi: 10.1186/s12916-025-04545-6.
4. Deng Z#, Zhang X#, Zhu A#, Yang X, Zhang Q, Yan H, Wu H, Zhang T, Moog C*, Su B*. Subset Remodeling of MAIT and NK Cells Correlates With Immune Reconstitution in People Living With HIV Following Four Years of Antiretroviral Therapy. JOURNAL OF MEDICAL VIROLOGY, 2025 Dec;97(12):e70732.
5. Yuan D#, Zhao F#, Liu Y, Liu S, Yan H, Liu L, Zhang T, Wang B*, Su B*. Deep sequencing reveals underestimated burden of integrase inhibitor resistance mutations in people living with HIV: a global individual patient data meta-analysis. EMERGING MICROBES & INFECTIONS, 2025 Nov 26:2595793.
6. Li L#, Yuan D#, Zhao F#, Shen Y, Cui C, Moog C, Sun L, Wang B, Liu L*, Zhang T*, Su B*. HIV-1 drug resistance and molecular transmission network analysis of newly diagnosed people living with HIV in Beijing, China: a retrospective study from 2015 to 2023. VIROLOGY JOURNAL, 2025 Nov 7;22(1):366.
7. He Z#, Luo Y#, Duan Z#, Su B#, Zeng W, Guo Y, Li Y, He X, Shi H, Zhou Z, Jiang C, Qin D, Zhang J, Kang Y*, Chen W*, Song X*. IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis. CIRCULATION, 2025 Dec 2;152(22):1564-1581.
8. Xiao W#, Qin S#, Li X#, Jin X#, Zhu A, He X, Duan X, Chen Y, Zhang Y, Fan N, Zheng Q, Li G, He Z, Chen K, Huang H, Wei X*, Moog C*, Su B*, Song X*. Tomatine as a versatile adjuvant boosts mRNA vaccine responses. MATERIALS TODAY BIO, 2025 Sep 27:35:102360.
9. Zhao F#, Li L#, Yuan D#, An X, Tian X, Wang B, Wu H, Zhang T*, Liu L*, Su B*. The performance of low HIV viral load values for the diagnosis of acute HIV infection in the Beijing PRIMO cohort. BMC INFECTIOUS DISEASES, 2025 Oct 10;25(1):1285.
10. Wang X#, Yang X#, Zhang X, Xia W, Zhang T, Wu H*, Su B*. Correlation between IL-18 secretion by peripheral blood mononuclear cells and NK cells activation after SARS-CoV-2 booster vaccination in HIV-1-infected individuals. INFECTIOUS DISEASES & IMMUNITY, 2025 Oct;5(4):p 306-308.
11. Yan H#, Duan H#, Han X, Sun J, Liang Q, Zhao Y, Ma Z, Ding N, Ren M, Jiang T, Zhang T, Su B*. Auxiliary Diagnostic Value of the Interferon Gamma-Induced Protein 10 mRNA Release Assay for Tuberculosis in People Living with HIV/AIDS - Beijing Municipality, China, 2022-2024. CHINA CDC WEEKLY, 2025 Aug 22;7(34):1106-1113.
12. Yuan D, Zhao F, Liu S, Yan H, Liu L, Zhang T, Wang B, Su B*. Research progress on second-generation integrase strand transfer inhibitor-based fixed-dose combination therapies. INFECTION CONTROL, 2025;2(2):26-31.
13. Yuan D#, Zhao F#, Liu S, Li L, Yan H, Liu L, Zhang T, Moog C, Wang B*, Su B*. Spatiotemporal patterns and influencing factors of genotypic resistance testing utilization among people living with HIV: A 10-year retrospective analysis at a tertiary care hospital in Beijing, China (2014-2023). BIOSAFETY AND HEALTH, 2025 May 8;7(3):192-198.
14. Han X#, Sun J#, Gao Y#, Yan H, He X, Ma Y, Xu P, Ding N, Zhang X, Ren M, Jiang T, Zhang T, Su B*. A nomogram for predicting unfavorable outcomes of antituberculosis treatment among individuals with AIDS combined with pulmonary tuberculosis in China. FRONTIERS IN IMMUNOLOGY, 2025 May 29:16:1594107.
15. Wang H#, Li S#, Wang R#, Wang X#, Zhang Y, Lu X, Sun J, Zhang T, Huang X*, Su B*, Wu H*, Li Z*. Dynamics and immunological signature of γδ T cells following antiretroviral therapy initiation in acute HIV-1 Infection. FRONTIERS IN IMMUNOLOGY, 2025 May 8:16:1554916.
16. Zhao F#, Yuan D#, Liu S, Liu Y, Yan H, Liu L, Li L, Moog C, Wang B*, Su B*. Association Between Baseline HIV-1 DNA Levels and Clinical Outcomes in People Living with HIV: A Meta-Analysis of Cohort Studies. EMERGING MICROBES & INFECTIONS, 2025 Dec;14(1):2508759.
17. Wei J#, Hui W#, Fang Y#, Jia H, Yang Y, Zhang T, Wu H, Su B*, Jiang T*. The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis. BMC INFECTIOUS DISEASES, 2025 Feb 19;25(1):239.
18. Wang X#, Yang X#, Zhang X#, Yan H, Jin J, Ma Z, Duan J, Zhang G, Huang T, Li Y, Wu H, Zhang T, Zhu A, Jin C, Song X*, Su B*. Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine. FRONTIERS IN IMMUNOLOGY, 2025 Feb 25:16:1554409.
19. Deng Z#, Yan H#, Lambotte O, Moog C, Su B*. HIV controllers: hope for a functional cure. FRONTIERS IN IMMUNOLOGY, 2025 Feb 25:16:1540932.
20. Xu Q#, Zhang Q#, Xu P#, Zhang T, Wu H, Zhang X*, Moog C*, Su B*. Impaired immune reconstitution in HIV infection: the role of CD4+ T-cell-associated NKG2D ligands, CD4+ T-cell subsets imbalance, and immune function deficiency. FRONTIERS IN IMMUNOLOGY, 2025 Feb 21:16:1541574.
21. Xu P#, Yuan D#, Moog C*, Su B*. Efforts toward achieving the goal of ending AIDS by 2030: from antiretroviral drugs to HIV vaccine and cure research. SCIENCE CHINA LIFE SCIENCES, 2025 Mar 4. doi: 10.1007/s11427-024-2840-4.
22. Xiao J#, Wang F#, Yan H, Wang B, Su B*, Lu X*, Zhang T*. Memory stem CD8+ T cells in HIV/Mtb mono- and co-infection: characteristics, implications, and clinical significance. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024 Dec 10:14:1485825.
23. Han X#, Wang X#, Han F#, Yan H, Sun J, Zhang X, Moog C, Zhang C*, Su B*. The cGAS-STING pathway in HIV-1 and Mycobacterium tuberculosis coinfection. INFECTION, 2024 Nov 7. doi: 10.1007/s15010-024-02429-0.
24. He X#, Wang X#, Li S, Li N, Li W, Hu Y, Guo N, Zheng Y*, Zheng H*, Su B*. Immunosenescence and its related comorbidities in older people living with HIV. INFECTIOUS DISEASES & IMMUNITY, 2024 Aug 21; DOI: 10.1097/ID9.0000000000000134.
25. Ye J#, Dong Y#, Lan Y#, Chen J#, Zhou Y#, Liu J#, Yuan D#, Lu X#, Guo W#, Zheng M#, Yang H#, Song X#, Liu C#, Zhou Q#, Zheng C#, Guo Q#, Yang X#, Zhang L#, Ge Z#, Liu L#, Yu F#, Han Y#, Huang H#, Hao M#, Ruan Y#, Wu J#, Li J#, Chen Q#, Ning Z#, Ling X#, Zhou C#, Liu X#, Bai J#, Gao Y#, Tong X#, Zhou K#, Mei F#, Yang Z#, Wang A#, Wei W#, Qiao R#, Luo X#, Huang X#, Wang J#, Shen X#, Hu F#, Zhang L#, Tan W#, Fan J#, Tu A#, Yu G#, Fang Y#, He S#, Chen X#, Wu D#, Zhang X#, Xin R#, He X#, Ren X#, Xu C#, Sun Y#, Li Y#, Liu G#, Li X#, Duan J#, Huang T#, Shao Y#, Feng Y#, Pan Q#, Su B#, Jiang T#, Zhao H#, Zhang T#, Chen F#, Hu B#, Wang H#, Zhao J#, Cai K#, Sun W#, Gao B#, Ning T#, Liang S#, Huo Y#, Fu G#, Li F#, Lin Y*, Xing H*, Lu H*. Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023. THE JOURNAL OF INFECTIOUS DISEASES, 2024 Aug 27:jiae303.
26. Ye J#, Lan Y#, Wang J#, Feng Y#, Lin Y#, Zhou Y#, Liu J#, Yuan D#, Lu X#, Guo W#, Zheng M#, Song X#, Zhou Q#, Yang H#, Zheng C#, Guo Q#, Yang X#, Yang K#, Zhang L#, Ge Z#, Liu L#, Yu F#, Han Y#, Huang H#, Hao M#, Chen Q#, Ling X#, Ruan Y#, Dong Y#, Zhou C#, Liu X#, Bai J#, Tong X#, Gao Y#, Yang Z#, Wang A#, Wei W#, Mei F#, Qiao R#, Luo X#, Huang X#, Chen J#, Hu F#, Shen X#, Tan W#, Tu A#, Zhang X##, He S, Ning Z#, Fan J#, Liu C#, Xu C#, Ren X#, Sun Y#, Li Y#, Liu G#, Li X#, Li J#, Duan J#, Huang T#, Liu S#, Yu G#, Wu D#, Shao Y#, Pan Q#, Zhang L#, Su B#, Wu J#, Jiang T#, Zhao H#, Zhang T#, Chen F#, Cai K#, Hu B#, Wang H#, Zhao J#, Gao B#, Sun W#, Ning T#, Li J#, Liang S#, Huo Y#, Fu G#, Chen X#, Li F*, Xing H*, Lu H*. Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China. THE JOURNAL OF INFECTIOUS DISEASES, 2024 Nov 15;230(5):1202-1214.
27. Fang D#, Liu Y#, Dou D, Su B*. The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies. VIROLOGICA SINICA, 2024 Oct;39(5):709-718.
28. Wang X#, Li Y#, Jin J, Chai X, Ma Z, Duan J, Zhang G, Huang T, Zhang X, Zhang T, Wu H, Cao Y, Su B*. Severe acute respiratory syndrome coronavirus 2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination. CHINESE MEDICAL JOURNAL, 2024 Nov 20;137(22):2734-2744.
29. Yuan D#, Zhao F#, Liu S, Liu Y, Yan H, Liu L, Su B#,*, Wang B*. Dual Infection of Different Clusters of HIV in People Living with HIV Worldwide: A Meta-Analysis Based on Next-Generation Sequencing Studies. AIDS PATIENT CARE AND STDS, 2024 Aug;38(8):348-357.
30. Han X#, Sun J#, Zhang Y#, Jiang T#, Zheng Q, Peng H, Wang Y, Xia W, Zhang T, Sun L, Yun X, Qin H*, Wu H*, Su B*. Population pharmacokinetics of Ainuovirine and exposure-response analysis in human immunodeficiency virus-infected individuals. CHINESE MEDICAL JOURNAL, 2024 Oct 20;137(20):2473-2482.
31. Li L#, Feng X#, Zhao F, Yuan D, An X, Tian X, Wu H, Su B*, Zhang T*, Liu L*. Real-world performance of HIV low viral load values in diagnosing acute HIV infection in a tertiary care hospital in Beijing, China. BMC INFECTIOUS DISEASES, 2024 Jun 15;24(1):587.
32. Sun J#, Han X#, Yan H#, Zhang X, Jiang T, Zhang T, Wu H, Kaminskiy G, Ma Y*, Karamov E*, Su B*. Advances in technology for the laboratory diagnosis of individuals with HIV/AIDS coinfected with Mycobacterium tuberculosis. BIOSAFETY AND HEALTH, 2024 Apr 26. doi:10.1016/j.bsheal.2024.04.003.
33. Yuan L#, Liu Z#, Zhang X, Wei F, Guo S, Guo N, Liu L, Ma Z, Ji Y, Wang R, Lu X, Li Z, Xia W, Wu H, Zhang T*, Su B*. Development of a droplet digital polymerase chain reaction assay for the sensitive detection of total and integrated HIV-1 DNA. CHINESE MEDICAL JOURNAL, 2024 Mar 20;137(6):729-736.
34. Wang Y#, Lan X#, Qiao Y#, Huo Y#, Wang L, Liang S, Yu M, Song M, Yan Y*, Su B*, Xu J*. Safety and immunogenicity of homologous prime-boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study. JOURNAL OF MEDICAL VIROLOGY, 2024 Jan;96(1):e29395.
35. Lin L, Zhu A, Su B*, Moog C*. Role of Fc-mediated Ab functions in HIV and SARS-CoV-2 vaccine prevention. INFECTION CONTROL, 2024;1(1):26-31.
36. Wang X#, Zhang X#, Lu X, Li Z, Liu L, Wu H, Zhang T, Su B*. Glut1 expression on CD8dim T cells is associated with immune recovery in HIV-1-infected individuals. CHINESE MEDICAL JOURNAL, 2023 Dec 20;136(24):2999-3001.
37. Jin J#, Wang X#, Li Y, Yang X, Wang H, Han X, Sun J, Ma Z, Duan J, Zhang G, Huang T, Zhang T, Wu H, Zhang X*, Su B*. Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+ T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine. CHINESE MEDICAL JOURNAL, 2023 Dec 20;136(24):2938-2947.
38. Li S#, Wang H#, Guo N#, Su B*, Lambotte O*, Zhang T*. Targeting the HIV Reservoir: Chimeric Antigen Receptor Therapy for HIV Cure. CHINESE MEDICAL JOURNAL, 2023 Nov 20;136(22):2658-2667.
39. Wang H#, Xu S#, Li S#, Su B*, Sherrill-Mix S*, Liang G*. Virome in immunodeficiency: What we know currently. CHINESE MEDICAL JOURNAL, 2023 Nov 20;136(22):2647-2657.
40. Li S#, Su B#, Wu H, He Q*, Zhang T*. Integrated analysis of gut and oral microbiome in men who have sex with men with HIV Infection. MICROBIOLOGY SPECTRUM, 2023 Oct 18:e0106423.
41. Li X#, Su B#, Yang L#, Kou Z#, Wu H, Zhang T, Liu L, Han Y, Niu M, Sun Y*, Li H*, Jiang T*. Highly sensitive and rapid point-of-care testing for HIV-1 infection based on CRISPR-Cas13a system. BMC INFECTIOUS DISEASES, 2023 Sep 25;23(1):627.
42. Wu X#, Wu G#, Ma P#, Wang R#, Li L#, Chen Y, Xu J, Li Y, Li Q, Yang Y, Wang L, Xin X, Qiao Y, Fu G*, Huang X*, Su B*, Zhang T*, Wang H*, Zou H*. Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China. NATURE COMMUNICATIONS, 2023 Sep 2;14(1):5334.
43. Wu X#, Wu G#, Ma P#, Wang R#, Li L#, Sun Y, Xu J, Li Y, Zhang T, Li Q, Yang Y, Wang L, Xin X, Qiao Y, Fang B, Lu Z, Zhou X, Chen Y, Liu Q, Fu G, Wei H*, Huang X*, Su B*, Wang H*, Zou H*. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis. INFECTIOUS DISEASES OF POVERTY, 2023 Aug 14;12(1):73.
44. Kuang YQ, Sun C, Ram DR, Moog C, Su B*. Editorial: Challenges and solutions for the incomplete immune restoration in HIV-infected patients under antiretroviral therapy. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023 Jun 14;13:1232699.
45. Su B#, Gao G#, Wang M#, Lu Y#, Li L#, Chen C#, Chen Y#, Song C, Yu F, Li Y, Liu Y, Luo Y, He H, Cheng C, Xu L, Zhang T, Sun L, Liu A, Xia W, Qin Y, Zhao Q*, Wei H*, Cai W*, Chen Y*, Zhang F*, Wu H*. Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96. THE LANCET REGIONAL HEALTH - WESTERN PACIFIC, 2023 Apr 24;36:100769.
46. Su B, Vanham G*. Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals. AIDS, 2023 Apr 1;37(5):837-839.
47. Wang H#, Zhu Z#, Zhang Y#, Jiang T, Zhang M, Wang Z, Zhang Y*, Zhao A*, Su B*. New insight into immune checkpoint inhibitors in the treatment of advanced renal cell carcinoma. SCIENCE CHINA LIFE SCIENCES, 2023 Apr;66(4):875-878.
48. Liu Y#, Li Z#, Lu X#, Kuang YQ#, Kong D, Zhang X, Yang X, Wang X, Mu T, Wang H, Zhang Y, Jin J, Xia W, Wu H, Zhang T, Moog C, Su B*. Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV-infected patients on antiretroviral therapy. JOURNAL OF MEDICAL VIROLOGY, 2023 Feb;95(2):e28559.
49. Zhang X#, Wang X#, Qin L#, Lu X, Liu Z, Li Z, Yuan L, Wang R, Jin J, Ma Z, Wu H, Zhang Y*, Zhang T*, Su B*. Changing roles of CD3+CD8low T cells in combating HIV-1 infection. CHINESE MEDICAL JOURNAL, 2023 Feb 20;136(4):433-445.
50. Jiang T#, Hou J#, Wei J, Mu T, Zhu G, Wang X, Qu D, Wu H, Zhang T, Su B*. A moderated serial mediation analysis of the association between HIV stigma and sleep quality in people living with HIV: a cross-sectional study. TRANSLATIONAL BEHAVIORAL MEDICINE, 2023 Jan 20;13(1):25-33.
51. Mu T#, Wei J#, Sun J, Jin J, Zhang T, Wu H, Su B*. Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis. CHINESE MEDICAL JOURNAL, 2022 Nov 20;135(22):2677-2686.
52. Li S#, Moog C#, Zhang T*, Su B*. HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection. CHINESE MEDICAL JOURNAL, 2022 Nov 20;135(22):2667-2676.
53. Li S, Yang X, Moog C, Wu H, Su B*, Zhang T*. Neglected mycobiome in HIV infection: Alterations, common fungal diseases and antifungal immunity. FRONTIERS IN IMMUNOLOGY, 2022 Nov 10;13:1015775.
54. Jin J, Wang X, Carapito R, Moog C*, Su B*. Advances in Research on COVID-19 Vaccination for People Living With HIV. INFECTIOUS DISEASES & IMMUNITY, 2022 Oct;2(4):213-218.
展开更多
学校介绍
首都医科大学建校于1960年，是北京市重点高等院校，著名泌尿外科专家、中国科学院院士、中国工程院院士、原全国人大常委会副委员长吴阶平教授为首任院长。学校由校本部和附属医院(即临床医学院)组成。校本部设有基础医学院、生物医学工程学院、公共卫生与家庭医学学院、高等职业教育学院、中医药学院、顺义校区、继续教育学院、护理学院、卫生事业管理与发展学院及首都医科大学国际教学部；附属医院包括宣武医院(第一临床医学院)、附属北京友谊医院(第二临床医学院)、附属北京朝阳医院(第三临床医学院)、附属北京同仁医院(第四临床医学院)、附属北京天坛医院(第五临床医学院)、附属北京安贞医院(第六临床医学院)、附属北京口腔医院(口腔医学院)、附属北京儿童医院(儿科医学院)、附属北京妇产医院(妇产医学院)、附属北京安定医院(精神卫生学院)、附属复兴医院(第八临床医学院)、附属北京中医医院(中医药临床医学院)和康复医学院。
学校和附属医院现有教职员工和医护人员22575人。有院士4人，正高职称700余人，副高职称1800余人。学校学科专业齐全，学科力量雄厚，在基础和临床各专业拥有一大批具有很高造诣的专家学者，现有3个国家级重点学科，有38个博士学位授予权学科，58个硕士学位授予权学科和2个博士后科研流动站。
校本部和附属医院总占地面积97.3万平方米，总建筑面积134万平方米 ，固定资产总值近46.5亿元，图书馆藏书108.3万册 ，住院病床10039张。学校开办的七年制专业中设有临床医学和口腔医学；五年制专业中设有临床医学、口腔医学、预防医学、护理学、中医学等；四年制专业中设有生物医学工程、中药学和康复治疗学。在临床医学专业中设有儿科医学、康复医学、医学影像、精神卫生与精神病学和医学检验5个专业方向；在生物医学工程专业中设有医学影像设备与技术和听力学专业方向。高等职业教育设有护理、医学检验、药学、医学影像技术、康复技术、口腔修复工艺、眼科验光、实验动物技术、中医学、中药制剂、医学信息、临床医学、预防医学、中药经营贸易和中医学美容专业方向15个专业。首都医科大学现已成为以培养高层次本科生与研究生为核心、以临床应用型人才为主和培养预防、康复、生物医学工程和医学基础各学科、各层次人才，位于全国先进医学院校行列的高等学府。
学校具有较强的学术发展与科研实力，在校本部和附属医院建有一批国家级和市级重点学科和重点实验室，建有高水平的国家级或市级研究和培训机构，如卫生部全科医学培训中心、临床医学研究所、基础医学研究所、神经科学研究所、眼科研究所、老年病医疗研究中心、泌尿外科研究所、心肺血管医疗研究中心、生命科学院、卫生毒理检测中心、生物工程技术研究中心、祖国医学研究所、临床疾病研究中心、中医肝病临床研究中心、生殖医学研究所、心血管疾病临床试验及社区干预中心和北京市卫生政策与卫生经济研究中心等。神经生物学、细胞生物学、电生理学、基础免疫学、实验寄生虫学、医学图像处理、生物医学、信息检测与处理、神经内科、神经外科、心脏内外科、肾移植、呼吸和消化内科、口腔颌面外科、眼科、耳鼻咽喉科、小儿血液病等领域在国内外享有较高声誉，很多学科的研究和医疗水平已经达到或接近国际先进水平。
学校十分重视对外交流与合作，改革开放以来，先后与世界20多个国家和地区签定了友好交流协议， 近十年中,先后接待美国、加拿大、英国、澳大利亚、法国、瑞典、日本、荷兰、意大利、德国、丹麦及台湾、香港和澳门等50多个国家和地区的专家学者8000余人次来校进行学术交流和参观访问。同时，学校积极选送教师、科研人员和管理干部出国进修、参加学术会议和考察访问。
展开更多